The bold promise of gene therapy for sickle cell disease-Reference-Cited by-同舟云学术

The bold promise of gene therapy for sickle cell disease

Published:2024-01-21 Issue:2 Volume:204 Page:381-382
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ware Russell E.¹²³^ORCID,Quinn Charles T.¹²^ORCID

Affiliation:

1. Division of Hematology Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

2. University of Cincinnati College of Medicine Cincinnati Ohio USA

3. Global Health Center, Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19296

Reference9 articles.

1. Available from:https://www.gov.uk/government/news/mhra‐authorises‐world‐first‐gene‐therapy‐that‐aims‐to‐cure‐sickle‐cell‐disease‐and‐transfusion‐dependent‐thalassemia. Accessed 26 Dec 2023.

2. Available from:https://www.fda.gov/news‐events/press‐announcements/fda‐approves‐first‐gene‐therapies‐treat‐patients‐sickle‐cell‐disease. Accessed 26 Dec 2023.

3. Available from:https://www.ema.europan.eu/en/news/first‐gene‐editing‐therapy‐treat‐beta‐thalassemia‐and‐severe‐sickle‐cell‐disease. Accessed 26 Dec 2023.

4. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021

5. Bone-Marrow Transplantation in a Patient with Sickle-Cell Anemia

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbiome in sickle cell disease: Pathophysiology and therapeutic insights;British Journal of Haematology;2024-08-29